A panel of experts from the Food and Drug Administration (FDA) by USA unanimously supported recommending a booster dose of the Modern in the elderly and population at risk.
This is the same recommendation that this panel made at the time for the Pfizer vaccine, whose third dose was already authorized by the FDA at the end of September and is already being administered in these groups.
The same committee will debate the recommendation on a booster dose for Johnson & Johnson’s (J&J) Janssen vaccine on Friday.
Support for the Moderna booster dose has been unanimous for those over 65 years of age, adults at risk of suffering the disease severely due to their medical condition and workers who are more exposed to contagion due to their occupation.
About seven million Americans have received the third dose of the COVID-19, including three million people in the last week, according to data provided this Wednesday by the White House pandemic response team.
US President Joe Biden expressed confidence that the FDA and the Centers for Disease Control (CDC) will end up approving Moderna and J&J booster doses, as they did with Pfizer, for those groups. and he calculated that such approval could arrive in the next two weeks.
In any case, he admitted that 66 million Americans still remain unvaccinated, a still “unacceptable” number.
.
Ricardo is a renowned author and journalist, known for his exceptional writing on top-news stories. He currently works as a writer at the 247 News Agency, where he is known for his ability to deliver breaking news and insightful analysis on the most pressing issues of the day.
